This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
$93.36
Share price
0.00%
Change (1 day)
44.43%
Change (1 year)
Categories
P/S ratio for ChemoCentryx (CCXI)
P/S ratio on November 25, 2022 (TTM) : 101
According to ChemoCentryx's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is N/A. At the end of 2022 the company had a P/S ratio of 47.5.
P/S ratio history for ChemoCentryx from 2012 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 47.5 | -40.54% |
| 2021 | 79.9 | 20.11% |
| 2020 | 66.6 | 0.44% |
| 2019 | 66.3 | 414.1% |
| 2018 | 12.9 | 266.45% |
| 2017 | 3.52 | -88.63% |
| 2016 | 30.9 | |
| 2015 | N/A | |
| 2014 | N/A | -100% |
| 2013 | 41.0 | -44.17% |
| 2012 | 73.4 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 1.86 | -98.15% | 🇺🇸 USA |
 | 5.87 | -94.16% | 🇺🇸 USA |
 | 1.93 | -98.08% | 🇬🇧 UK |
 | 2.33 | -97.68% | 🇺🇸 USA |
 | 4.16 | -95.86% | 🇺🇸 USA |
 | 4.73 | -95.29% | 🇺🇸 USA |
 | 2.05 | -97.96% | 🇺🇸 USA |
 | 1.05 | -98.96% | 🇮🇱 Israel |
 | 3.21 | -96.81% | 🇺🇸 USA |